Skip to main content

Table 2 RT-3PE-QTVI parameters in HCM patients versus control group

From: Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging

  HCM patients (N = 50) Control group (N = 40) p value
Ea(cm/sec)
 AS 3.35 ± 1.15 8.14 ± 2.23 < 0.001
 AN 3.58 ± 1.25 8.87 ± 1.81 < 0.001
 AL 4.24 ± 1.50 9.25 ± 1.80 < 0.001
 IL 3.88 ± 1.44 10.26 ± 2.01 < 0.001
 IN 3.51 ± 1.46 9.18 ± 1.57 < 0.001
 IS 3.44 ± 1.42 8.20 ± 1.31 < 0.001
Aa (cm/sec)
 AS 5.12 ± 1.84 6.48 ± 0.87 < 0.001
 AN 5.22 ± 1.20 7.08 ± 0.56 < 0.001
 AL 5.93 ± 1.43 7.21 ± 0.65 < 0.001
 IL 6.02 ± 1.58 7.59 ± 1.13 < 0.001
 IN 5.68 ± 1.46 7.80 ± 1.32 < 0.001
 IS 5.10 ± 1.27 6.63 ± 0.68 < 0.001
E a / Aa
 AS 0.71 ± 0.26 1.27 ± 0.43 < 0.001
 AN 0.69 ± 0.20 1.24 ± 0.18 < 0.001
 AL 0.74 ± 0.28 1.29 ± 0.23 < 0.001
 IL 0.63 ± 0.22 1.45 ± 0.33 < 0.001
 IN 0.63 ± 0.25 1.21 ± 0.29 < 0.001
 IS 0.69 ± 0.18 1.26 ± 0.32 < 0.001
 E/Em ratio 21.47 ± 5.36 10.01 ± 3.94 < 0.001
  1. Ea early diastolic velocity of mitral annulus, Aa late-diastolic velocity of mitral annulus, E mitral inflow peak velocity in early diastole, Em mean value of Ea at six loci in mitral annulus, AS anterior septum, AN anterior wall, AL anterolateral wall, IL inferolateral wall, IN inferior wall, IS inferior septum. Values are expressed as the mean ± SD